Authors
Loading...
Transcriptomic profiling reveals Cd39 promotes neutrophil expansion and immunosuppression in bone marrow, suggesting targeted therapies may enhance anti-leukemic efficacy.
Mai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: